Trading to commence on the OTCQB in the US

Summary by AI BETAClose X

Abingdon Health plc will commence trading on the OTCQB Venture Market in the United States on April 21, 2026, under the ticker symbol ABDXF, while continuing to trade on AIM as ABDX. This expansion into the US market follows the second phase of a facility expansion at its Madison, Wisconsin site, which aims to provide manufacturing capabilities in both the USA and UK to offer customers geographic optionality and address supply chain uncertainties. The company anticipates this move will increase its relevance to US investors, enhance share liquidity, and benefit existing investors without incurring additional reporting obligations or significant ongoing costs.

Disclaimer*

UK 100

Latest directors dealings